ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025
Correction: Effectiveness of PARP Inhibitor Maintenance Therapy in Ovarian Cancer by BRCA1/2 and a Scar-Based HRD Signature in Real-World Practice.
Debra L Richardson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.